N14.2 Nephropathy induced by unspecified drug, medicament or biological substance

Name of the Condition

• Nephropathy Induced by Unspecified Drug, Medicament or Biological Substance
• ICD-10 Code: N14.2

Summary

Nephropathy induced by an unspecified drug, medicament, or biological substance refers to kidney damage caused by exposure to a medication or biological agent where the specific substance is not identified. This condition involves injury to renal structures, potentially leading to impaired kidney function. Management focuses on identifying and discontinuing the causative agent, along with supportive care to preserve renal function.

Causes

This nephropathy is caused by toxic or adverse effects of a drug, medicament, or biological substance on the kidneys. The exact mechanism may involve direct cellular toxicity, immune-mediated reactions, or metabolic byproducts. Since the substance is unspecified, the cause is attributed to an unidentified agent rather than a specific medication or biological product.

Risk Factors

• Medication use: Exposure to drugs with known nephrotoxic potential, even if the specific agent is unknown.
• Biological agent exposure: Use of biological substances (e.g., vaccines, immunoglobulins) without clear attribution.
• Underlying kidney disease: Pre-existing renal impairment may increase susceptibility to drug-induced injury.
• Polypharmacy: Concurrent use of multiple medications, raising the risk of unidentified nephrotoxic effects.

Symptoms

• Reduced urine output or changes in urine color.
• Swelling in the legs, ankles, or face (edema).
• Fatigue or generalized weakness.
• Nausea or vomiting.
• Elevated blood pressure.

Diagnosis

Diagnosis involves a thorough patient history to identify potential drug or biological agent exposure, even if the specific substance is unknown. Laboratory tests assess kidney function (e.g., serum creatinine, BUN) and urinalysis for protein or blood. Imaging or biopsy may be used to evaluate renal structure and exclude other causes. Documentation of exposure to an unspecified agent supports the diagnosis.

Treatment Options

Treatment focuses on discontinuing the suspected agent and providing supportive care. This may include fluid management, blood pressure control, and medications to mitigate inflammation or oxidative stress. In severe cases, dialysis may be required to support renal function until recovery occurs.

Prognosis and Follow-Up

Prognosis depends on the extent of kidney damage and timely removal of the causative agent. Early intervention often leads to partial or full recovery of renal function. Follow-up includes monitoring kidney function tests and blood pressure to detect residual impairment or progression.

Complications

• Acute kidney injury or chronic kidney disease.
• Electrolyte imbalances (e.g., hyperkalemia).
• Fluid overload or hypertension.
• Rarely, progression to end-stage renal disease.

Lifestyle & Prevention

• Avoid unnecessary medications and discuss risks with healthcare providers.
• Maintain hydration and a balanced diet to support kidney health.
• Monitor for adverse reactions when starting new drugs or biological agents.
• Report symptoms like swelling or changes in urination promptly.

When to Seek Professional Help

Seek medical attention if you experience sudden swelling, reduced urine output, unexplained fatigue, or elevated blood pressure, especially after starting a new medication or biological agent.

Tips for Medical Coders

Document the clinical context of drug or biological agent exposure, even if the specific substance is unspecified. Ensure the diagnosis aligns with the patient's history and laboratory findings. Code N14.2 is appropriate when the causative agent is not identified but drug-induced nephropathy is clinically suspected.